Wnt3a regulates mitochondrial biogenesis through p38/CREB pathway

Biochem Biophys Res Commun. 2019 Aug 27;516(3):1019-1025. doi: 10.1016/j.bbrc.2016.05.004. Epub 2016 May 2.

Abstract

Wnt3a is established as an important regulator of various developmental processes, especially in osteogenesis, adipogenesis and mitochondrial biogenesis. Numerous studies reported Wnt3a regulates osteogenesis and adipogenesis, but the mechanisms by which Wnt3a regulates mitochondrial biogenesis are not well understood. In this study, results suggested that Wnt3a stimulates mitochondrial biogenesis by increasing the expression of mitochondrial biogenesis genes and regulators, as well as mitochondrial copy number in adipocytes. As a key mediator of canonical Wnt/β-catenin pathway, β-catenin knockdown had no effect on basal or Wnt3a-mediated mitochondrial biogenesis in adipocytes, which suggested that Wnt3a-mediated mitochondrial biogenesis was independent of β-catenin-dependent canonical Wnt/β-catenin pathway. However, Wnt3a inhibited p38/CREB (p38 mitogen-activated protein kinase/cAMP response element-binding protein) signaling activation and p38 inhibitor impaired Wnt3a-stimulated mitochondrial biogenesis, indicating p38/CREB pathway could be involved in the regulation of Wnt3a-mediated mitochondrial biogenesis in adipocytes. In conclusion, our data showed that Wnt3a stimulates mitochondrial biogenesis in adipocytes, which is at least partially through activation of p38/CREB pathway.

Keywords: Adipocyte; Mitochondrial biogenesis; Wnt3a; p38/CREB pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3-L1 Cells
  • Adipocytes / cytology
  • Adipocytes / drug effects
  • Adipocytes / metabolism
  • Adipogenesis / genetics
  • Animals
  • Cyclic AMP Response Element-Binding Protein / metabolism*
  • HEK293 Cells
  • Humans
  • Imidazoles / pharmacology
  • Mice
  • Mitochondria / genetics
  • Mitochondria / metabolism*
  • Organelle Biogenesis*
  • Protein Kinase Inhibitors / pharmacology
  • Pyrimidines / pharmacology
  • RNA Interference
  • Wnt Signaling Pathway / genetics
  • Wnt3A Protein / genetics
  • Wnt3A Protein / metabolism*
  • beta Catenin / genetics
  • beta Catenin / metabolism
  • p38 Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • p38 Mitogen-Activated Protein Kinases / metabolism*

Substances

  • CTNNB1 protein, human
  • Cyclic AMP Response Element-Binding Protein
  • Imidazoles
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Wnt3A Protein
  • beta Catenin
  • p38 Mitogen-Activated Protein Kinases
  • SB 239063